{"id":35832,"date":"2024-06-05T12:29:16","date_gmt":"2024-06-05T10:29:16","guid":{"rendered":"https:\/\/petsvetcheck.de\/krankheiten-und-stoerungen\/hund\/malignes-fibroeses-histiozytom-tumoren-des-weichteilgewebes\/"},"modified":"2026-10-15T14:52:27","modified_gmt":"2026-10-15T12:52:27","slug":"malignant-fibrous-histiocytoma-soft-tissue-tumors","status":"publish","type":"krankheit","link":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/","title":{"rendered":"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma)"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","krankheitsort":[143],"haufigkeit":[136],"organsystem_krankheiten":[239,234],"class_list":["post-35832","krankheit","type-krankheit","status-publish","hentry","krankheitsort-general-whole-body","haufigkeit-b-en","organsystem_krankheiten-general-full-body","organsystem_krankheiten-tumors","entry"],"acf":{"synonyme":"","synonyme_en":"Soft Tissue Sarcoma","titel_en":"Malignant Fibrous Histiocytoma","weitere_suchbegriffe":"","triage":"yellow","triage_begruendung":"Malignant soft tissue tumor; wide removal and oncological planning are important.","definition":"Malignant Fibrous Histiocytoma (MFH) is a rare, malignant soft tissue tumor in dogs, characterized by aggressive growth and a high tendency to metastasize.","ursachen":"Malignant fibrous histiocytomas belong to the sarcomas, a group of tumors originating from mesenchymal cells. These cells are the precursors of connective tissue, muscle, fat tissue, and other soft tissues. MFH is characterized by a mixture of fiber-forming and histiocytic (macrophage-like) cells. The exact cell line from which MFH originates is not fully understood, but it is assumed that the tumor cells derive from undifferentiated mesenchymal precursor cells.   \n\nThe causes for the development of a malignant fibrous histiocytoma are not fully understood. Genetic factors, environmental influences, as well as chronic inflammatory conditions or traumas could play a role in tumor development. There are no specific breed predispositions, but older dogs are more frequently affected.  \n\nGenetic mutations that lead to uncontrolled cell division are often the driving force behind tumor development. These mutations can occur spontaneously or be induced by external influences such as environmental toxins or radiation. However, the exact genetic signature of MFH in dogs is still a subject of research.  ","auswahl_symptome_rot":[33365,33720,33602,33510,34019],"auswahl_symptome_blau":[33424,33958,33634,34305,34220,33237,33976],"auswahl_symptome_grun":[33832,33793,33332,33810,34231],"erganzungen_zu_symptomen":"Symptoms of a malignant fibrous histiocytoma can vary depending on the location and size of the tumor. The tumor often appears as a fast-growing, painless lump in the subcutaneous tissue. However, it can also occur in deeper soft tissues and exert pressure on surrounding structures there.  \n\nIn advanced stages, symptoms such as lameness, swelling, weight loss, and general weakness may occur. Metastases, especially to the lungs, can lead to respiratory distress. In some dogs, systemic symptoms such as fever or anemia may also be observed, indicating a malignant disease.  \n\nSince the symptoms are nonspecific, it is important to consult a veterinarian for any newly appearing or unusually fast-growing lump to obtain an accurate diagnosis.","zusammenfassung":"Malignant Fibrous Histiocytoma (MFH) is an aggressive soft tissue tumor in dogs that arises from mesenchymal precursor cells. The exact causes are unclear, but genetic factors, environmental influences, and chronic inflammatory conditions could play a role. Older dogs are more frequently affected. Symptoms include swelling, pain, and loss of appetite. Diagnosis is made through clinical examination, biopsy, and imaging procedures such as X-ray or MRI to assess the extent and possible metastases.    \n\nTreatment often requires surgical removal of the tumor, supplemented by radiation therapy or chemotherapy in metastatic cases. The prognosis ranges from guarded to poor, especially for metastatic tumors. Regular follow-up examinations are important to detect recurrence early. Since the exact causes are not fully understood, there are no specific prevention measures. Nevertheless, regular veterinary examinations and avoidance of carcinogens can reduce the overall cancer risk.    \n\nResearch focuses on the genetic basis of MFH to develop more targeted treatments. New diagnostic methods and treatment forms such as immunotherapy are being investigated. A healthy lifestyle could be supportive, and studies on the role of nutrition could offer new therapeutic approaches.  ","diagnose":"The diagnosis of a malignant fibrous histiocytoma begins with a thorough clinical examination and medical history. Since the tumor often appears non-specific externally, further diagnostic procedures are required to make an accurate diagnosis. \n\nA biopsy of the tumor tissue is the most important diagnostic measure. Tissue samples are taken and examined histopathologically. Microscopic examination typically shows a mixture of spindle-shaped and histiocytic cells with high mitotic activity, indicating the aggressiveness of the tumor.  \n\nImaging procedures such as X-ray, ultrasound, or MRI can be used to assess the extent of the tumor and possible metastases. A chest X-ray can help detect lung metastases, which frequently occur with MFH. ","behandlung":"The treatment of malignant fibrous histiocytoma requires a multimodal approach. Surgical removal of the tumor is the primary treatment option. It is advisable to completely remove the tumor with sufficient safety margins to minimize the likelihood of recurrence.  \n\nIn cases where complete surgical resection is not possible, radiation therapy can be used to destroy the remaining tumor cells. Chemotherapy may be considered, especially for metastatic tumors or if surgical removal was not complete. However, the effectiveness of chemotherapy for MFH is limited and depends on the individual tumor biology.  \n\nTreatment is often palliative, especially for metastatic or inoperable tumors, and aims to improve the animal's quality of life and relieve symptoms.","prognose":"The prognosis for dogs with malignant fibrous histiocytoma is generally guarded to poor, especially if the tumor has metastasized or cannot be completely surgically removed. Survival time depends on various factors, including tumor size, location, metastasis, and the dog's overall health status. \n\nDogs in which the tumor could be completely removed and showed no signs of metastasis have a better prognosis. Nevertheless, the recurrence rate is high, and regular follow-up examinations are required to detect recurrence early. \n\nThe dog's quality of life is paramount in treatment, and decisions should be made in the best interest of the animal, weighing the burden of treatments against their impact on quality of life.","ausblick_auf_aktuelle_forschung":"Research on malignant fibrous histiocytoma (MFH) in dogs is steadily advancing, as it is an aggressive form of soft tissue sarcoma that occurs in both humans and animals. Currently, many studies focus on better understanding the genetic and molecular basis of these tumors. Researchers are investigating specific mutations and genetic markers that could contribute to the development of MFH in order to develop more targeted and effective treatment strategies. The identification of such genetic anomalies could enable the development of personalized therapies that are better tailored to the individual needs of each dog.   \n\nAnother research focus is the improvement of diagnostic procedures. Currently, MFH is often diagnosed through a combination of imaging and biopsy, but efforts are underway to develop less invasive methods. Advances in imaging technology, such as the use of high-resolution MRIs and CT scans, could significantly improve diagnostic accuracy and help detect tumors at an earlier stage. Additionally, work is being done on biomarkers that can be detected in the blood to facilitate monitoring and management of the disease.   \n\nTherapeutic approaches are also an important area of research. Traditionally, MFH tumors are treated by surgical removal, often in combination with radiation therapy and chemotherapy. However, current studies are investigating the potential of newer treatment forms such as immunotherapy and targeted therapy. Immunotherapies use the body's own immune system to attack cancer cells, while targeted therapies attack specific anomalies in cancer cells. By combining these methods with traditional treatment forms, researchers hope for improved outcomes in affected dogs.    \n\nIn veterinary medicine, the role of nutrition and overall health in the treatment of MFH is also being investigated. A healthy lifestyle could play a supportive role in the treatment and possibly also in the prevention of tumors. Studies investigating the influence of diet and nutritional supplements on tumor growth in dogs could provide valuable insights and lead to new supportive therapeutic approaches.  ","zusatzlicher_inhalt_im_hauptteil":"Since the exact causes for the development of malignant fibrous histiocytoma are not fully understood, there are no specific preventive measures to prevent the occurrence of these tumors.\n\nHowever, regular veterinary examinations and early detection of tumors can help improve the prognosis. Monitoring older dogs for unusual swelling or lumps and prompt evaluation by a veterinarian are important for detecting malignant tumors early. \n\nAvoiding known carcinogens and maintaining a healthy lifestyle, including a balanced diet and regular exercise, can reduce the overall cancer risk in dogs, even though they do not represent specific prevention against MFH.","haufig_gestellte_fragen_faqs":"<ol>\n \t<li><b>What is a Malignant Fibrous Histiocytoma?<\/b>\nA malignant fibrous histiocytoma (MFH) is a type of malignant tumor that arises from soft tissue. These tumors are aggressive, grow rapidly, and can spread to other parts of the body. They occur in both humans and dogs.  <\/li>\n \t<li><b>What symptoms does a dog with MFH show?<\/b>\nSymptoms can vary depending on the location of the tumor, but often include swelling or masses under the skin, lameness, pain, or general signs of discomfort such as loss of appetite and weight loss.<\/li>\n \t<li><b>How is MFH diagnosed in dogs?<\/b>\nDiagnosis is usually made through a combination of physical examination, imaging (such as X-ray, ultrasound, CT, or MRI), and a biopsy of the tumor for histological examination.<\/li>\n \t<li><b>What treatment options are available for dogs with MFH?<\/b>\nThe primary treatment is usually surgical removal of the tumor, followed by radiation therapy or chemotherapy to destroy remaining cancer cells and prevent recurrence.<\/li>\n \t<li><b>What is the prognosis for dogs with MFH?<\/b>\nThe prognosis depends on various factors, including the size and location of the tumor, the stage at diagnosis, and the chosen treatment. Generally, the prognosis is guarded, as MFH is aggressive and has a tendency to metastasize. <\/li>\n \t<li><b>Can MFH tumors be prevented in dogs?<\/b>\nThere are no specific measures to prevent MFH, as the exact causes are not fully understood. However, a healthy lifestyle and regular veterinary examinations can help detect tumors early. <\/li>\n \t<li><b>Are there breeds that are more susceptible to MFH?<\/b>\nMFH can theoretically occur in any dog breed, but some studies indicate that larger dog breeds may have a higher risk. Further research is required to better understand genetic predispositions. <\/li>\n \t<li><b>Is MFH painful in dogs?<\/b>\nYes, MFH can be painful, especially if the tumor grows near nerves or in joints. Pain can also result from metastases or secondary effects of the tumor. <\/li>\n \t<li><b>What role does nutrition play in the treatment of MFH?<\/b>\nA balanced diet can support a dog's general well-being and possibly strengthen the immune system, which can be helpful in fighting cancer. However, there is no specific diet known to directly influence MFH. <\/li>\n \t<li><b>How can I help my dog with MFH?<\/b>\nEnsure that your dog receives regular veterinary check-ups and follows the recommended treatment. Support your dog with a balanced diet, appropriate exercise, and plenty of love and attention to improve their quality of life. <\/li>\n<\/ol>","literaturangaben":"<ul>\n \t<li>Gleiser, C. A., Raulston, G. L., Jardine, J. H., & Gray, K. N. (1979). Malignant fibrous histiocytoma in dogs and cats. Veterinary Pathology, 16(2), 199\u2013208.   https:\/\/doi.org\/10.1177\/030098587901600205<\/li>\n \t<li>Thoolen, R. J. M. M., Vos, J. H., Van der Linde-Sipman, J. S., De Weger, R. A., Van Unnik, J. A. M., Misdorp, W., & Van Dijk, J. E. (1992). Malignant fibrous histiocytomas in dogs and cats: An immunohistochemical study. Research in Veterinary Science, 53(2), 198\u2013204.   https:\/\/doi.org\/10.1016\/0034-5288(92)90110-n<\/li>\n \t<li>Do, S. H., Hong, I. H., Park, J. K., Ji, A. R., Kim, T. H., Kwak, D. M., & Jeong, K. S. (2009). Two different types of malignant fibrous histiocytomas from pet dogs. Journal of Veterinary Science, 10(2), 169\u2013171.   https:\/\/doi.org\/10.4142\/jvs.2009.10.2.169<\/li>\n \t<li>Choi, H., Kwon, Y., Chang, J., Jeong, S., Lee, H., Kim, J., Jung, J., & Lee, Y. (2011). Undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma) of the head in a dog. Journal of Veterinary Medical Science, 73(2), 235\u2013239.   https:\/\/doi.org\/10.1292\/jvms.10-0183<\/li>\n \t<li>Kim, K., Shin, J., Kim, H., Kim, H., Kim, J., Do, S., & Kim, H. (2022). Multiple undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma) with extradural involvement in a 7-year-old Labrador Retriever. Veterinary Sciences, 9(1), Article 3. https:\/\/doi.org\/10.3390\/vetsci9010003  <\/li>\n \t<li>Bray, J. P. (2016). Soft tissue sarcoma in the dog\u2014Part 1: A current review. Journal of Small Animal Practice, 57(10), 510\u2013519.   https:\/\/doi.org\/10.1111\/jsap.12556<\/li>\n \t<li>Bray, J. P. (2017). Soft tissue sarcoma in the dog\u2014Part 2: Surgical margins, controversies and a comparative review. Journal of Small Animal Practice, 58(2), 63\u201372.   https:\/\/doi.org\/10.1111\/jsap.12629<\/li>\n \t<li>Das, S., Idate, R., Lana, S. E., Regan, D. P., & Duval, D. L. (2023). Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. Scientific Reports, 13, Article 10422.   https:\/\/doi.org\/10.1038\/s41598-023-37266-y<\/li>\n \t<li>Dell'Anno, F., Giugliano, R., Listorti, V., & Razzuoli, E. (2024). A review on canine and human soft tissue sarcomas: New insights on prognosis factors and treatment measures. Veterinary Sciences, 11(8), Article 362.   https:\/\/doi.org\/10.3390\/vetsci11080362<\/li>\n<\/ul>","symptome_ausgeblendet":"","erganzungen":"","faq":[{"frage":"1. What is a malignant fibrous histiocytoma?","antwort":"A Malignant Fibrous Histiocytoma (MFH) is a type of malignant tumor that arises from soft tissue. These tumors are aggressive and can grow rapidly and spread to other parts of the body. They occur in both humans and dogs."},{"frage":"2. What symptoms does a dog with MFH show?","antwort":"Symptoms can vary depending on the location of the tumor, but often include swelling or masses under the skin, lameness, pain, or general signs of discomfort such as loss of appetite and weight loss."},{"frage":"3. How is MFH diagnosed in dogs?","antwort":"Diagnosis is typically made through a combination of physical examination, imaging (such as X-ray, ultrasound, CT, or MRI), and a biopsy of the tumor to perform a histological examination."},{"frage":"4. What treatment options are available for dogs with MFH?","antwort":"The primary treatment is usually surgical removal of the tumor, often followed by radiation therapy or chemotherapy to destroy remaining cancer cells and prevent recurrence."},{"frage":"5. What is the prognosis for dogs with MFH?","antwort":"The prognosis depends on various factors, including the size and location of the tumor, the stage at diagnosis, and the chosen treatment. Generally, the prognosis is guarded, as MFH is aggressive and has a tendency to metastasize."},{"frage":"6. Can MFH tumors be prevented in dogs?","antwort":"There are no specific measures to prevent MFH, as the exact causes are not fully understood. However, a healthy lifestyle and regular veterinary examinations can help detect tumors early."},{"frage":"7. Are there breeds that are more susceptible to MFH?","antwort":"MFH can theoretically occur in any dog breed, but some studies suggest that larger dog breeds may have a higher risk. Further research is needed to better understand genetic predispositions."},{"frage":"8. Is MFH painful in dogs?","antwort":"Yes, MFH can be painful, especially if the tumor grows near nerves or in joints. Pain can also result from metastases or secondary effects of the tumor."},{"frage":"9. What role does nutrition play in the treatment of MFH?","antwort":"A balanced diet can support a dog's overall well-being and potentially strengthen the immune system, which may be helpful in fighting cancer. However, no specific diet is known to directly affect MFH."},{"frage":"10. How can I help my dog with MFH?","antwort":"Make sure your dog receives regular veterinary check-ups and follows the recommended treatment. Support your dog with a balanced diet, appropriate exercise, and plenty of love and attention to improve their quality of life. "}],"faq_html":null},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.9 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma) in dogs<\/title>\n<meta name=\"description\" content=\"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma)\" \/>\n<meta property=\"og:description\" content=\"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/\" \/>\n<meta property=\"og:site_name\" content=\"PETSVETCHECK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/petsvetcheck.de\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-15T12:52:27+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/malignant-fibrous-histiocytoma-soft-tissue-tumors\\\/\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/malignant-fibrous-histiocytoma-soft-tissue-tumors\\\/\",\"name\":\"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma) in dogs\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#website\"},\"datePublished\":\"2024-06-05T10:29:16+00:00\",\"dateModified\":\"2026-10-15T12:52:27+00:00\",\"description\":\"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/malignant-fibrous-histiocytoma-soft-tissue-tumors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/malignant-fibrous-histiocytoma-soft-tissue-tumors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/diseases-and-disorders\\\/dog\\\/malignant-fibrous-histiocytoma-soft-tissue-tumors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\",\"name\":\"PETSVETCHECK\",\"description\":\"Gesundheit f\u00fcr Hund und Katze\",\"publisher\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#organization\",\"name\":\"PETSVETCHECK\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/petsvetcheck.de\\\/wp-content\\\/uploads\\\/logo-petsvetcheck-dunkel.svg\",\"contentUrl\":\"https:\\\/\\\/petsvetcheck.de\\\/wp-content\\\/uploads\\\/logo-petsvetcheck-dunkel.svg\",\"width\":1246,\"height\":169,\"caption\":\"PETSVETCHECK\"},\"image\":{\"@id\":\"https:\\\/\\\/petsvetcheck.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/petsvetcheck.de\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma) in dogs","description":"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/","og_locale":"en_US","og_type":"article","og_title":"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma)","og_description":"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.","og_url":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/","og_site_name":"PETSVETCHECK","article_publisher":"https:\/\/www.facebook.com\/petsvetcheck.de\/","article_modified_time":"2026-10-15T12:52:27+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/","url":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/","name":"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma) in dogs","isPartOf":{"@id":"https:\/\/petsvetcheck.de\/en\/#website"},"datePublished":"2024-06-05T10:29:16+00:00","dateModified":"2026-10-15T12:52:27+00:00","description":"Learn more about malignant fibrous histiocytoma (MFH), an aggressive soft tissue tumor. Treatment and prognosis for dogs.","breadcrumb":{"@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/petsvetcheck.de\/en\/diseases-and-disorders\/dog\/malignant-fibrous-histiocytoma-soft-tissue-tumors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/petsvetcheck.de\/en\/"},{"@type":"ListItem","position":2,"name":"Soft Tissue Cancer in Dogs (Malignant Fibrous Histiocytoma)"}]},{"@type":"WebSite","@id":"https:\/\/petsvetcheck.de\/en\/#website","url":"https:\/\/petsvetcheck.de\/en\/","name":"PETSVETCHECK","description":"Gesundheit f\u00fcr Hund und Katze","publisher":{"@id":"https:\/\/petsvetcheck.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/petsvetcheck.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/petsvetcheck.de\/en\/#organization","name":"PETSVETCHECK","url":"https:\/\/petsvetcheck.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/petsvetcheck.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/petsvetcheck.de\/wp-content\/uploads\/logo-petsvetcheck-dunkel.svg","contentUrl":"https:\/\/petsvetcheck.de\/wp-content\/uploads\/logo-petsvetcheck-dunkel.svg","width":1246,"height":169,"caption":"PETSVETCHECK"},"image":{"@id":"https:\/\/petsvetcheck.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/petsvetcheck.de\/"]}]}},"_links":{"self":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheit\/35832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheit"}],"about":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/types\/krankheit"}],"acf:post":[{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34231"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33810"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33332"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33793"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33832"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33976"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33237"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34220"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34305"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33634"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33958"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33424"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/34019"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33510"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33602"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33720"},{"embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/symptom\/33365"}],"wp:attachment":[{"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/media?parent=35832"}],"wp:term":[{"taxonomy":"krankheitsort","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/krankheitsort?post=35832"},{"taxonomy":"haufigkeit","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/haufigkeit?post=35832"},{"taxonomy":"organsystem_krankheiten","embeddable":true,"href":"https:\/\/petsvetcheck.de\/en\/wp-json\/wp\/v2\/organsystem_krankheiten?post=35832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}